Siemens to sell its healthcare business

Siemens Limited’s Board of Directors approve sale of healthcare undertaking for Rs 30,500 million


The transaction is subject to requisite regulatory, statutory and shareholder approvals

The Board of Directors of Siemens Limited has approved the sale and transfer of its Healthcare undertaking, as a going concern on a slump sale basis, for a sale consideration of Rs 30,500 million (Indian Rupees Thirty Thousand Five Hundred million), to Siemens Healthcare Private Limited, a subsidiary of Siemens AG. The transaction is subject to requisite regulatory, statutory and shareholder approvals.

The consideration for the proposed transaction, recommended by the Audit committee, is based on the valuation undertaken by two independent valuers - Deloitte Touche Tohmatsu India LLP and KPMG India Private Limited. Citigroup Global Markets India Pvt. Ltd. is acting as the transaction advisor to Siemens Limited.

Mr Sunil Mathur, managing director and chief executive officer, Siemens Limited, said, "This transaction, follows Siemens AG's global strategy of managing its Healthcare business under a separately-managed company. Over 85 percent of Siemens Ltd Healthcare revenues are currently derived from products imported from Siemens AG. Significant Management focus, including investments will be needed in finding appropriate products and solutions to meet the growing demands of the Indian market. As there are limited synergies between the Healthcare and other businesses of Siemens Ltd, this transaction will enable Siemens Ltd to increase its focus on, and capital allocation to Power Generation, Transmission and Distribution, Mobility, Industrial Automation and Smart Cities segments while enabling Siemens AG to further strengthen its focus on the Healthcare segment in India, by aligning it with its global strategy and management framework."

Key Rationale for the Proposed Transaction

Healthcare in India: Changing Scenario
Increasing Government spending, preference for locally manufactured products
Growth being driven by Tier II / III cities, where preference is for value products
Siemens Ltd.'s Healthcare undertaking is highly dependent on Siemens AG and its subsidiaries for products and technical know-how
Significant long-term investments required for localization of products and solutions


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email